Where does Lek Pharmaceuticals d. d. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Lek Pharmaceuticals d. d. ranks #9,070 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Lek Pharmaceuticals d. d. hold?

Lek Pharmaceuticals d. d. holds 35 US utility patents granted between 2015 and 2021, spanning 16 technology areas.

What is Lek Pharmaceuticals d. d.'s Innovation Score?

Lek Pharmaceuticals d. d. has an Innovation Score of 34.0 out of 100 (46th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Lek Pharmaceuticals d. d. focus on?

Lek Pharmaceuticals d. d.'s top technology area is C07D (Heterocyclic Compounds) with 17 patents, ranking #514 of 3,165 assignees active in that subclass. Grants appear in 16 CPC subclasses total.

Is Lek Pharmaceuticals d. d.'s patent grant rate increasing or decreasing?

Lek Pharmaceuticals d. d.'s recent grant velocity is -94% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Lek Pharmaceuticals d. d.'s patents?

Lek Pharmaceuticals d. d.'s patents average 12.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Lek Pharmaceuticals d. d. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Lek Pharmaceuticals d. d.

USPTO PatentsView assignee record - 35 granted patents across 16 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Lek ranks #9,070 of 49,997 tracked US assignees by granted-patent volume, with 35 patents across 16 technology areas.

#9,070
of 49,997 US assignees by volume: 46th percentile
by Innovation Score (34.0/100): 12.5
avg claims per patent: -94%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9070 · Foreign Corporation #9,070 · 35 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 35 grants
UPPER-Q #9,070/49,997
PHOTO-FINISH Kissei Pharmaceutical
CPC-FOCUS C07D · 16 areas
INNOV-THIN 34.0/100
CLAIMS-RICH 12.5 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -94% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Kissei Pharmaceutical Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Lek’s 34.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.4 pts (36%) Velocity 0.0 pts (0%) Breadth 14.1 pts (41%) Claim depth 7.5 pts (22%)

Qualcomm Incorporated · highest

85
Joyson Safety… · near

34
Lek Pharmaceuticals… · this assignee

34
Omix-ada · near

34
Yutou Technology… · near

34
Magnacom · near

34
3D Lighting… · lowest

7

What this shows Lek's Innovation Score is 34.0/100 (46th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Lek?

Each dot is one of Lek’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Lek’s own 12.5 claims/patent is at or below the 15.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Lek vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Lek's grants concentrate

Lek Pharmaceuticals d. d. is a focused PatentsView assignee: 16 CPC subclasses with 48.6% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2016 (14 grants) versus a trough of 1 in 2018. By volume, Lek sits between Kissei Pharmaceutical Co., Ltd. and Mbda Deutschland GmbH.

Kissei Pharmaceut…

35
Koch-glitsch

35
Kuraray Europe

35
Longsand

35
Lepton Computing

35
Logistics and Sup…

35
Maersk Drilling A…

35
Mbda Deutschland

35
Lek Pharmaceutica… ◀

35

What this shows Lek holds 35 patents at rank #9,069, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Lek

By rank, the assignees closest to #9,069 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Lek's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Lek, neither rank-band nor same-CPC leaders (those blocks stay above). In C07D (Heterocyclic Compounds), Lek ranks #514 of 3,165 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (34 here).

Yutou Technology (HANGZHOU) Co., Ltd. 34 Joyson Safety Systems Japan G.K. 34 Omix-ada, Inc. 34 Magnacom Ltd. 34

Lek's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 46th percentile higher than 46% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Lek Pharmaceuticals d. d. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	9	25.7%
2016	14	40.0%
2017	5	14.3%
2018	1	2.9%
2019	4	11.4%
2021	2	5.7%

Which technologies does Lek Pharmaceuticals d. d. patent most?

C07D - Heterocyclic Compounds 17

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 12

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 12

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 10

C07C - Acyclic OR Carbocyclic Compounds 9

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 7

C07K - Peptides 5

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 5

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 3

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 3

C12Y - Enzymes 1

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 1

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 1

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 1

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

Top 15 of 16 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Lek Pharmaceuticals d. d.'s patent record in context - here's where to go next.

Lek Pharmaceuticals d. d.'s lead technology class is C07D (Heterocyclic Compounds), 48.6% of its portfolio - see every assignee active in that class. Explore C07D
Ranked #9,070 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Lek Pharmaceuticals d. d. against Kissei Pharmaceutical Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.